Life Cycle of Orphan Drug Development & Commercialization 2013 is a conference dedicated to
Rare disease research units for large and niche pharma companies
Rare disease research methods used in early stages of orphan drug development
How to increase patient recruitment in clinical trials
Translational medicine to be effective in orphan drug development
FDA Safety and Innovation Act and its impact on orphan drug reserach and development
Who should Attend
Vice Presidents, Heads, Scientists and Directors responsible for: :
Orphan Drug Development
Rare Disease Discovery
Research & Development
Translational Research
Regulatory Affairs
Clinical Operations
Reimbursement
Past Events
Life Cycle of Orphan Drug Development & Commercialization 2013 - 16-18 Jan 2013, Omni Parker House, Boston, Massachusetts, United States (33220)
Life Cycle of Orphan Drug Development & Commercialization 2026
Important
Please, check "Life Cycle of Orphan Drug Development & Commercialization" official website for possible changes, before making any traveling arrangements
Event Categories
Government & Global Issues: Law & Regulations
Health & Medicine: Hematology, Medical laboratories, Oncology, Pharma
